Cargando…

P345: IN SILICO DRUG REPURPOSING STUDY AND MOLECULAR SIGNATURE IDENTIFICATION ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales:	Kiraz Durmaz, Yagmur, Budak, Betül, Yağmur Tükel, Ezgi, Turanli, Beste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428297/ http://dx.doi.org/10.1097/01.HS9.0000968292.46372.31

Ejemplares similares

P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Oikonomou, Athanasios, et al.
Publicado: (2023)

Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
por: Boulos, Joelle C., et al.
Publicado: (2021)

Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia
por: Koca, Duygu, et al.
Publicado: (2020)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

Attachment, Psychological Wellbeing, and Educational Development among Child Members of Transnational Families
por: Manyeruke, Gloria, et al.
Publicado: (2021)

Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2021)

The contribution of neurocognitive situation, physical capacity and daily life activities to quality of life in childhood acute lymphoblastic leukemia survivors
por: KELEŞ GÜLNERMAN, Elif, et al.
Publicado: (2021)

Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021)

Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia
por: Natarajan, Aparna, et al.
Publicado: (2019)

Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
por: Rahman, Md. Rezanur, et al.
Publicado: (2019)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

In Silico Repurposed Drugs against Monkeypox Virus
por: Lam, Hilbert Yuen In, et al.
Publicado: (2022)

Arthritis as presenting manifestation of acute lymphoblastic leukemia in children
por: Brix, Ninna, et al.
Publicado: (2014)

P368: GENOMIC LANDSCAPE OF PEDIATRIC ACUTE B LYMPHOBLASTIC LEUKEMIA IN CHINA
por: Gao, Yangyang, et al.
Publicado: (2023)

On the Integration of In Silico Drug Design Methods for Drug Repurposing
por: March-Vila, Eric, et al.
Publicado: (2017)

P359: DOUBLE-HIT LEUKEMIA: A VERY HIGH-RISK SUBTYPE PH-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA
por: Huang, Zicong, et al.
Publicado: (2023)

P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Sun, Qian, et al.
Publicado: (2023)

Turkish Neonatal Society guideline for the follow-up of high-risk newborn infants
por: Acunaş, Betul, et al.
Publicado: (2018)

345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2021)

Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021)

In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
por: Xu, Eric, et al.
Publicado: (2023)

Relating genomic variation to drug response in childhood acute lymphoblastic leukemia by multiplexed targeted sequencing
por: Wesolowska, Agata, et al.
Publicado: (2010)

P323: UNCOVERING SUBCLONAL METABOLIC VULNERABILITIES IN ACUTE LYMPHOBLASTIC LEUKEMIA AT SINGLE CELL RESOLUTION
por: Mönnig, Maximilian, et al.
Publicado: (2023)

P1576: NOVEL APPROACHES TO MANAGEMENT OF COVID-19 IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
por: Chudnova, Tatiana, et al.
Publicado: (2023)

Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer
por: Kori, Medi, et al.
Publicado: (2023)

P345: Prison health environment and patients safety in Cote d'Ivoire
por: Anongba, S, et al.
Publicado: (2013)

P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
por: Baruchel, André, et al.
Publicado: (2023)

LncRNA CRNDE Promotes the Progression of B-cell Precursor Acute Lymphoblastic Leukemia by Targeting the miR-345-5p/CREB Axi
por: Wang, Weimin, et al.
Publicado: (2020)

P321: TNF-MEDIATED CELL DEATH: AN ACTIONABLE TARGET FOR IMMUNOTHERAPY IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Dourthe, Marie-Emilie, et al.
Publicado: (2023)

P404: IMMUNOGLOBULIN GENE REARRANGEMENT IN KOREAN PATIENTS WITH B-LYMPHOBLASTIC LEUKEMIA – AN IMMUNOPHENOTYPE AND REPERTOIRE ANALYSIS
por: Chu, Daehyun, et al.
Publicado: (2023)

Piplartine-Inspired 3,4,5-Trimethoxycinnamates: Trypanocidal, Mechanism of Action, and In Silico Evaluation
por: Filho, Carlos S. M. B., et al.
Publicado: (2023)

Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas
por: Wang, Weimin, et al.
Publicado: (2021)

Identification of immune and stromal cell infiltration-related gene signature for prognosis prediction in acute lymphoblastic leukemia
por: Yu, Wen-Liang, et al.
Publicado: (2022)

P1586: IN-HOSPITAL MORTALITY AND POOR PROGNOSIS FACTORS ASSESSMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND COVID-19.
por: Ivanova, D., et al.
Publicado: (2022)

P1709: FERTILITY PRESERVATION FOR YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIAS IN ITALY: A CAMPUS ALL SURVEY.
por: Giglio, F., et al.
Publicado: (2022)

P403: HIGH EXPRESSION OF STAT5 INDICATES POOR PROGNOSIS IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Xu, Xiuli, et al.
Publicado: (2023)

P328: CHARACTERIZATION OF A DUX4-R INHIBITOR AS A POSSIBLE TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Salomè, Mara, et al.
Publicado: (2023)

P374: THROMBOTIC EVENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: EXPERIENCE OF ITALIAN AIEOP CENTERS (2009-2017)
por: Mattera, Raffaele, et al.
Publicado: (2023)

P338: SLC7A11 PROMOTES ARGININE BIOSYNTHESIS IN ACUTE LYMPHOBLASTIC LEUKEMIA WITH IMMUNOTHERAPEUTIC POTENTIAL
por: LI, Jiazheng, et al.
Publicado: (2023)

P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?
por: Stutterheim, Janine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_74pnfffgsp8du40fu0nf7uqlk8